Net profit of Godavari Drugs declined 8.26% to Rs 1.00 crore in the quarter ended September 2025 as against Rs 1.09 crore during the previous quarter ended September 2024. Sales rose 2.15% to Rs 26.65 crore in the quarter ended September 2025 as against Rs 26.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.6526.09 2 OPM %7.4711.12 - PBDT1.721.83 -6 PBT1.121.25 -10 NP1.001.09 -8 Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Godavari Drugs has revised the Annual General Meeting of the company which was scheduled to be held on 28 August 2025. The meeting will now be held on 27 September 2025.Powered by Capital Market - Live News

Godavari Drugs announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live News

Net profit of Godavari Drugs declined 36.20% to Rs 1.04 crore in the quarter ended June 2025 as against Rs 1.63 crore during the previous quarter ended June 2024. Sales declined 26.08% to Rs 23.81 crore in the quarter ended June 2025 as against Rs 32.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.8132.21 -26 OPM %12.1410.03 - PBDT1.902.56 -26 PBT1.302.01 -35 NP1.041.63 -36 Powered by Capital Market - Live News